scholarly journals Memory Binding Test Distinguishes Amnestic Mild Cognitive Impairment and Dementia from Cognitively Normal Elderly

2017 ◽  
Vol 32 (1) ◽  
pp. 29-39 ◽  
Author(s):  
Herman Buschke ◽  
Wenzhu B. Mowrey ◽  
Wendy S. Ramratan ◽  
Molly E. Zimmerman ◽  
David A. Loewenstein ◽  
...  
2017 ◽  
Vol 32 (8) ◽  
pp. 1037-1038 ◽  
Author(s):  
Herman Buschke ◽  
Wenzhu B Mowrey ◽  
Wendy S Ramratan ◽  
Molly E Zimmerman ◽  
David A Loewenstein ◽  
...  

2011 ◽  
Vol 7 ◽  
pp. S540-S541 ◽  
Author(s):  
Jan Laczó ◽  
Ross Andel ◽  
Kamil Vlcek ◽  
Martin Vyhnálek ◽  
Václav Mataska ◽  
...  

2019 ◽  
Vol 31 (12) ◽  
pp. 1721-1730 ◽  
Author(s):  
Xiao Wang ◽  
Tao Li ◽  
Haifeng Zhang ◽  
Tingting Sun ◽  
Lingchuan Xiong ◽  
...  

ABSTRACTBackground:Episodic memory starts to decline very early in the development of Alzheimer’s disease (AD). Subtle impairments in memory binding may be detected in mild cognitive impairment (MCI). This study aims to examine the psychometric properties of the Chinese version of the memory binding test (MBT).Methods:One hundred and sixty-four subjects (26 individuals with AD, 67 individuals with amnestic MCI (aMCI), 30 individuals with subjective cognitive impairment (SCI), and 41 cognitively normal elderly individuals (NC)) participated in the study. Twenty-two subjects repeated the assessment of the MBT within 6 weeks (± 2 weeks). Pearson correlation was used to calculate the convergent validity. The test––retest reliability was determined by the calculation of the intraclass correlation coefficient (ICC). Discriminative validity was calculated to evaluate the receiver–operating characteristic curves. The optimal index was chosen by comparing the area under the curve for specificity and sensitivity ≥ 0.80. The optimal cutoff score of the index was chosen to maximize the sum of sensitivity and specificity.Results:The absolute value of the convergent validity of the direct indexes of MBT ranged from 0.443 to 0.684. The ICC for each of direct indexes was 0.887–0.958. Total delayed paired recall (TDPR) was the optimal index for discriminating aMCI from NC. The cutoff score for TDPR was ≤25 to distinguish aMCI from NC (sensitivity = 0.896, specificity = 0.707).Conclusion:The Chinese version of MBT is a valid and reliable instrument to detect MCI.


2021 ◽  
pp. 1-14
Author(s):  
Juan F. Martínez-Florez ◽  
Juan D. Osorio ◽  
Judith C. Cediel ◽  
Juan C. Rivas ◽  
Ana M. Granados-Sánchez ◽  
...  

Background: Amnestic mild cognitive impairment (aMCI) is the most common preclinical stage of Alzheimer’s disease (AD). A strategy to reduce the impact of AD is the early aMCI diagnosis and clinical intervention. Neuroimaging, neurobiological, and genetic markers have proved to be sensitive and specific for the early diagnosis of AD. However, the high cost of these procedures is prohibitive in low-income and middle-income countries (LIMCs). The neuropsychological assessments currently aim to identify cognitive markers that could contribute to the early diagnosis of dementia. Objective: Compare machine learning (ML) architectures classifying and predicting aMCI and asset the contribution of cognitive measures including binding function in distinction and prediction of aMCI. Methods: We conducted a two-year follow-up assessment of a sample of 154 subjects with a comprehensive multidomain neuropsychological battery. Statistical analysis was proposed using complete ML architectures to compare subjects’ performance to classify and predict aMCI. Additionally, permutation importance and Shapley additive explanations (SHAP) routines were implemented for feature importance selection. Results: AdaBoost, gradient boosting, and XGBoost had the highest performance with over 80%success classifying aMCI, and decision tree and random forest had the highest performance with over 70%success predictive routines. Feature importance points, the auditory verbal learning test, short-term memory binding tasks, and verbal and category fluency tasks were used as variables with the first grade of importance to distinguish healthy cognition and aMCI. Conclusion: Although neuropsychological measures do not replace biomarkers’ utility, it is a relatively sensitive and specific diagnostic tool for aMCI. Further studies with ML must identify cognitive performance that differentiates conversion from average MCI to the pathological MCI observed in AD.


2016 ◽  
Vol 53 (4) ◽  
pp. 1585-1595 ◽  
Author(s):  
Wenzhu B. Mowrey ◽  
Richard B. Lipton ◽  
Mindy J. Katz ◽  
Wendy S. Ramratan ◽  
David A. Loewenstein ◽  
...  

SLEEP ◽  
2018 ◽  
Vol 42 (3) ◽  
Author(s):  
Noam Alperin ◽  
John Wiltshire ◽  
Sang H Lee ◽  
Alberto R Ramos ◽  
Rene Hernandez-Cardenache ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document